A Study Investigating the Actual Use of Therapeutics in Patients Hospitalized with COVID-19

Exploratory Assessment of Therapeutic Drug Utilization in Hospitalized Patients with COVID-19: An Observational Study - Evaluation of Therapeutic Use in COVID-19 Hospitalized Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056047

Enrollment

600

Registered

2024-11-05

Start date

2024-11-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients meeting all of the following criteria will be included in this study: 1) Hospitalized patients treated with Ensitrelvir or Remdesivir between November 2022 and August 2024 2) Patients for whom all of the following essential data are available: Start and end dates of treatment Positive SARS-CoV-2 test result COVID-19 outcomes

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria are excluded from the study. 1) Patients who were treated "offlabel" 2) Patients who refuse to participate in this study

Design outcomes

Primary

Measure	Time frame
Survival at Day 28 Time to Discharge SARS-CoV2 antigen titer	—

Countries

Japan

Contacts

Public ContactMasahiro Kinoshita

Shionogi & Co., Ltd. Medical Affairs

masahiro.kinoshita@shionogi.co.jp06-6202-2161

Outcome results